Keel Point’s AbbVie ABBV Stock Holding History

Keel Point’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.22M	Buy	11,955 +476	+4%	+$88.4K	0.15%	102
2025 Q1	$2.41M	Buy	11,479 +1,204	+12%	+$252K	0.19%	93
2024 Q4	$1.83M	Buy	10,275 +633	+7%	+$112K	0.15%	101
2024 Q3	$1.9M	Buy	9,642 +473	+5%	+$93.4K	0.16%	98
2024 Q2	$1.75M	Buy	9,169 +2,925	+47%	+$559K	0.16%	101
2024 Q1	$1.14M	Buy	6,244 +445	+8%	+$81K	0.12%	120
2023 Q4	$899K	Buy	5,799 +280	+5%	+$43.4K	0.11%	124
2023 Q3	$823K	Buy	5,519 +663	+14%	+$98.8K	0.11%	119
2023 Q2	$654K	Sell	4,856 -406	-8%	-$54.7K	0.09%	136
2023 Q1	$839K	Buy	5,262 +1,593	+43%	+$254K	0.12%	121
2022 Q4	$593K	Buy	3,669 +663	+22%	+$107K	0.09%	147
2022 Q3	$404K	Buy	3,006 +24	+0.8%	+$3.23K	0.07%	156
2022 Q2	$420K	Buy	2,982 +448	+18%	+$63.1K	0.07%	163
2022 Q1	$411K	Buy	2,534 +81	+3%	+$13.1K	0.06%	170
2021 Q4	$332K	Buy	2,453 +178	+8%	+$24.1K	0.04%	191
2021 Q3	$245K	Sell	2,275 -70	-3%	-$7.54K	0.03%	222
2021 Q2	$264K	Buy	2,345 +2	+0.1%	+$225	0.03%	212
2021 Q1	$254K	Buy	2,343 +282	+14%	+$30.6K	0.02%	220
2020 Q4	$221K	Buy	+2,061	New	+$221K	0.02%	222
2019 Q1	–	Sell	-4,492	Closed	-$414K	–	190
2018 Q4	$414K	Hold	4,492	–	–	0.06%	134
2018 Q3	$425K	Buy	4,492 +1	+0%	+$95	0.05%	115
2018 Q2	$416K	Buy	4,491 +46	+1%	+$4.26K	0.06%	100
2018 Q1	$421K	Sell	4,445 -1,967	-31%	-$186K	0.06%	101
2017 Q4	$620K	Sell	6,412 -900	-12%	-$87K	0.09%	83
2017 Q3	$650K	Sell	7,312 -1,109	-13%	-$98.6K	0.1%	80
2017 Q2	$611K	Buy	8,421 +220	+3%	+$16K	0.12%	83
2017 Q1	$534K	Sell	8,201 -290	-3%	-$18.9K	0.11%	88
2016 Q4	$532K	Buy	8,491 +1,107	+15%	+$69.4K	0.12%	80
2016 Q3	$466K	Buy	7,384 +883	+14%	+$55.7K	0.18%	83
2016 Q2	$403K	Buy	+6,501	New	+$403K	0.17%	92
2016 Q1	–	Sell	-3,905	Closed	-$231K	–	126
2015 Q4	$231K	Sell	3,905 -728	-16%	-$43.1K	0.12%	112
2015 Q3	$252K	Buy	4,633 +3	+0.1%	+$163	0.14%	89
2015 Q2	$322K	Buy	4,630 +109	+2%	+$7.58K	0.15%	78
2015 Q1	$265K	Buy	+4,521	New	+$265K	0.13%	80